Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
Farmers Insurance
AstraZeneca
Queensland Health
Dow
Johnson and Johnson
Merck
Baxter

Generated: May 20, 2018

DrugPatentWatch Database Preview

RAVOCAINE AND NOVOCAIN W/ LEVOPHED Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Ravocaine And Novocain W/ Levophed patents expire, and what generic alternatives are available?

Ravocaine And Novocain W/ Levophed is a drug marketed by Eastman Kodak and is included in one NDA.

The generic ingredient in RAVOCAINE AND NOVOCAIN W/ LEVOPHED is norepinephrine bitartrate; procaine hydrochloride; propoxycaine hydrochloride. There are four drug master file entries for this compound. Additional details are available on the norepinephrine bitartrate; procaine hydrochloride; propoxycaine hydrochloride profile page.
Summary for RAVOCAINE AND NOVOCAIN W/ LEVOPHED
Drug patent expirations by year for RAVOCAINE AND NOVOCAIN W/ LEVOPHED

US Patents and Regulatory Information for RAVOCAINE AND NOVOCAIN W/ LEVOPHED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eastman Kodak RAVOCAINE AND NOVOCAIN W/ LEVOPHED norepinephrine bitartrate; procaine hydrochloride; propoxycaine hydrochloride INJECTABLE;INJECTION 008592-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
QuintilesIMS
Medtronic
Deloitte
Baxter
Farmers Insurance
Julphar
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.